{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:22:53Z","timestamp":1791235373180,"version":"4.1.0"},"publisher-location":"Cham","reference-count":102,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319228211","type":"print"},{"value":"9783319228228","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-22822-8_3","type":"book-chapter","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T02:26:16Z","timestamp":1443579976000},"page":"23-42","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["EBV-Specific Immune Response: Early Research and Personal Reminiscences"],"prefix":"10.1007","author":[{"given":"D. J.","family":"Moss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. P.","family":"Lutzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,1]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.4049\/jimmunol.165.9.4831","volume":"165","author":"NE Annels","year":"2000","unstructured":"Annels NE, Callan MF, Tan L, Rickinson AB (2000) Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response. J Immunol 165:4831\u20134841","journal-title":"J Immunol"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0304-3835(78)94347-1","volume":"4","author":"T Bakacs","year":"1978","unstructured":"Bakacs T, Svedmyr E, Klein E (1978) EBV-related cytotoxicity of Fc receptor negative T lymphocytes separated from the blood of infectious mononucleosis patients. Cancer Lett 4:185\u2013189","journal-title":"Cancer Lett"},{"key":"3_CR3","first-page":"70","volume":"60","author":"CJ Bishop","year":"1985","unstructured":"Bishop CJ, Moss DJ, Ryan JM, Burrows SR (1985) T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines. Clin Exp Immunol 60:70\u201377","journal-title":"Clin Exp Immunol"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.171.1.345","volume":"171","author":"SR Burrows","year":"1990","unstructured":"Burrows SR, Sculley TB, Misko IS, Schmidt C, Moss DJ (1990) An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3). J Exp Med 171:345\u2013349","journal-title":"J Exp Med"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/nm0896-906","volume":"2","author":"MF Callan","year":"1996","unstructured":"Callan MF, Steven N, Krausa P, Wilson JD, Moss PA, Gillespie GM, Bell JI, Rickinson AB, McMichael AJ (1996) Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 2:906\u2013911","journal-title":"Nat Med"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1172\/JCI10590","volume":"106","author":"MF Callan","year":"2000","unstructured":"Callan MF, Fazou C, Yang H, Rostron T, Poon K, Hatton C, McMichael AJ (2000) CD8+ T-cell selection, function, and death in the primary immune response in vivo. J Clin Investig 106:1251\u20131261","journal-title":"J Clin Investig"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S0140-6736(75)93014-7","volume":"1","author":"RL Carter","year":"1975","unstructured":"Carter RL (1975) Infectious mononucleosis: model for self-limiting lymphoproliferation. Lancet 1:846\u2013849","journal-title":"Lancet"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/ijc.2910190312","volume":"19","author":"SH Chan","year":"1977","unstructured":"Chan SH, Wallen WC, Levine PH, Periman P, Perlin E (1977) Lymphocyte responses to EBV-associated antigens in infectious mononucleosis, and Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma patients, with the leukocyte adherence inhibition assay. Int J Cancer J 19:356\u2013363","journal-title":"Int J Cancer J"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/bjc.1983.106","volume":"47","author":"DH Crawford","year":"1983","unstructured":"Crawford DH, Iliescu V, Edwards AJ, Beverley PC (1983) Characterisation of Epstein-Barr virus-specific memory T cells from the peripheral blood of seropositive individuals. Br J Cancer 47:681\u2013686","journal-title":"Br J Cancer"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"7632","DOI":"10.1073\/pnas.81.23.7632","volume":"81","author":"T Dambaugh","year":"1984","unstructured":"Dambaugh T, Hennessy K, Chamnankit L, Kieff E (1984) U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 81:7632\u20137636","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR11","first-page":"443","volume":"5","author":"A de Schryver","year":"1969","unstructured":"de Schryver A, Friberg S Jr, Klein G, Henle W, Henle G, De-The G, Clifford P, Ho HC (1969) Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. Clin Exp Immunol 5:443\u2013459","journal-title":"Clin Exp Immunol"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ijc.2910130311","volume":"13","author":"A de Schryver","year":"1974","unstructured":"de Schryver A, Klein G, Hewetson J, Rocchi G, Henle W, Henle G, Moss DJ, Pope JH (1974) Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA). Int J Cancer 13:353\u2013362","journal-title":"Int J Cancer"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"7048","DOI":"10.1073\/pnas.82.20.7048","volume":"82","author":"C Delisi","year":"1985","unstructured":"Delisi C, Berzofsky JA (1985) T-cell antigenic sites tend to be amphipathic structures. Proc Natl Acad Sci USA 82:7048\u20137052","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR14","doi-asserted-by":"crossref","unstructured":"de-The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bronkamm GW, Feorino P et al (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt\u2019s lymphoma from Ugandan prospective study. Nature 274:756\u2013761","DOI":"10.1038\/274756a0"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/jcp.27.8.647","volume":"27","author":"JM Edwards","year":"1974","unstructured":"Edwards JM, McSwiggan DA (1974) Studies on the diagnostic value of an immunofluorescence test for EB virus-specific IgM. J Clin Pathol 27:647\u2013651","journal-title":"J Clin Pathol"},{"key":"3_CR16","first-page":"271","volume-title":"The Epstein-Barr virus: recent advances","author":"MA Epstein","year":"1986","unstructured":"Epstein MA, Morgan AJ (1986) Progress with subunits vaccines against the virus. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus: recent advances. William Heinemann medical books, London, pp 271\u2013289"},{"key":"3_CR17","first-page":"855","volume":"40","author":"P Gerber","year":"1968","unstructured":"Gerber P, Monroe JH (1968) Studies on leukocytes growing in continuous culture derived from normal human donors. J Natl Cancer Inst 40:855\u2013866","journal-title":"J Natl Cancer Inst"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.med.56.082103.104727","volume":"56","author":"S Gottschalk","year":"2005","unstructured":"Gottschalk S, Rooney CM, Heslop HE (2005) Post-transplant lymphoproliferative disorders. Annu Rev Med 56:29\u201344","journal-title":"Annu Rev Med"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0042-6822(77)90292-6","volume":"76","author":"E Henderson","year":"1977","unstructured":"Henderson E, Miller G, Robinson J, Heston L (1977) Efficiency of transformation of lymphocytes by Epstein-Barr virus. Virology 76:152\u2013163","journal-title":"Virology"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1128\/jb.91.3.1248-1256.1966","volume":"91","author":"G Henle","year":"1966","unstructured":"Henle G, Henle W (1966) Immunofluorescence in cells derived from Burkitt\u2019s lymphoma. J Bacteriol 91:1248\u20131256","journal-title":"J Bacteriol"},{"key":"3_CR21","first-page":"322","volume":"43","author":"G Henle","year":"1976","unstructured":"Henle G, Henle W (1976) Serum IgA antibodies to Epstein-Barr virus (EBV)-related antigens a new feature of nasopharyngeal carcinoma. Bibl Haematol 43:322\u2013325","journal-title":"Bibl Haematol"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-3-642-67236-1_4","volume-title":"The Epstein-Barr virus","author":"W Henle","year":"1979","unstructured":"Henle W, Henle G (1979) Seroepidemiology of the virus. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, New York, pp 61\u201378"},{"key":"3_CR23","first-page":"677","volume-title":"Epstein-Barr virus and associated diseases","author":"G Henle","year":"1984","unstructured":"Henle G, Henle W (1984) Epstein-Barr virus: past, present and future. In: Levine PH, Ablashi DV, Pearson GR, Kottaridis SD (eds) Epstein-Barr virus and associated diseases. Martinus Nijhoff Publishing, Boston\/Dordrecht\/Lancaster, pp 677\u2013686"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1126\/science.157.3792.1064","volume":"157","author":"W Henle","year":"1967","unstructured":"Henle W, Diehl V, Kohn G, Zur Hausen H, Henle G (1967) Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157:1064\u20131065","journal-title":"Science"},{"key":"3_CR25","unstructured":"Henle W, Henle G, Ho HC, Burtin P, Cachin Y, Clifford P, de Schryver A, de-The G, Diehl V, Klein G (1970a) Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Nat Cancer Inst 44:225\u2013231"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1126\/science.169.3941.188","volume":"169","author":"W Henle","year":"1970","unstructured":"Henle W, Henle G, Zajac BA, Pearson G, Waubke R, Scriba M (1970b) Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science 169:188\u2013190","journal-title":"Science"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ijc.2910080212","volume":"8","author":"G Henle","year":"1971","unstructured":"Henle G, Henle W, Klein G (1971a) Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells. Int J Cancer 8:272\u2013282","journal-title":"Int J Cancer"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/infdis\/124.1.58","volume":"124","author":"W Henle","year":"1971","unstructured":"Henle W, Henle G, Niederman JC, Klemola E, Haltia K (1971b) Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis. J Infect Dis 124:58\u201367","journal-title":"J Infect Dis"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0046-8177(74)80006-7","volume":"5","author":"W Henle","year":"1974","unstructured":"Henle W, Henle GE, Horwitz CA (1974) Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Hum Pathol 5:551\u2013565","journal-title":"Hum Pathol"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-3083.1979.tb01347.x","volume":"10","author":"HE Johnsen","year":"1979","unstructured":"Johnsen HE, Madsen M, Kristensen T (1979) Lymphocyte subpopulations in man: suppression of PWM-induced B-cell proliferation by infectious mononucleosis T cells. Scand J Immunol 10:251\u2013255","journal-title":"Scand J Immunol"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0022-1759(74)90003-9","volume":"5","author":"ME Kaplan","year":"1974","unstructured":"Kaplan ME, Clark C (1974) An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods 5:131\u2013135","journal-title":"J Immunol Methods"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1073\/pnas.55.6.1628","volume":"55","author":"G Klein","year":"1966","unstructured":"Klein G, Clifford P, Klein E, Stjernsward J (1966) Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci USA 55:1628\u20131635","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR33","first-page":"1027","volume":"39","author":"G Klein","year":"1967","unstructured":"Klein G, Clifford P, Klein E, Smith RT, Minowada J, Kourilsky FM, Burchenal JH (1967) Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. J Natl Cancer Inst 39:1027\u20131044","journal-title":"J Natl Cancer Inst"},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1084\/jem.128.5.1011","volume":"128","author":"G Klein","year":"1968","unstructured":"Klein G, Pearson G, Nadkarni JS, Nadkarni JJ, Klein E, Henle G, Henle W, Clifford P (1968) Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med 128:1011\u20131020","journal-title":"J Exp Med"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1084\/jem.129.4.697","volume":"129","author":"G Klein","year":"1969","unstructured":"Klein G, Pearson G, Henle G, Henle W, Goldstein G, Clifford P (1969) Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. 3. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera. J Exp Med 129:697\u2013705","journal-title":"J Exp Med"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1749-6632.1976.tb41647.x","volume":"276","author":"E Klein","year":"1976","unstructured":"Klein E, Becker S, Svedmyr E, Jondal M, Vanky F (1976) Tumor infiltrating lymphocytes. Ann N Y Acad Sci 276:207\u2013216","journal-title":"Ann N Y Acad Sci"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/iai.17.1.28-35.1977","volume":"17","author":"PK Lai","year":"1977","unstructured":"Lai PK, Alpers MP, MacKay-Scollay EM (1977) Development of cell-mediated immunity to Epstein-Barr herpesvirus in infectious mononucleosis as shown by leukocyte migration inhibition. Infect Immun 17:28\u201335","journal-title":"Infect Immun"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1084\/jem.150.6.1310","volume":"150","author":"M Lipinski","year":"1979","unstructured":"Lipinski M, Fridman WH, Tursz T, Vincent C, Pious D, Fellous M (1979) Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level. J Exp Med 150:1310\u20131322","journal-title":"J Exp Med"},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/infdis\/125.4.403","volume":"125","author":"G Miller","year":"1972","unstructured":"Miller G, Niederman JC, Stitt DA (1972) Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines. J Infect Dis 125:403\u2013406","journal-title":"J Infect Dis"},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1073\/pnas.77.7.4247","volume":"77","author":"IS Misko","year":"1980","unstructured":"Misko IS, Moss DJ, Pope JH (1980) HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Proc Natl Acad Sci USA 77:4247\u20134250","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR41","first-page":"2757","volume":"66","author":"GE Moore","year":"1966","unstructured":"Moore GE, Grace JT Jr, Citron P, Gerner R, Burns A (1966) Leukocyte cultures of patients with leukemia and lymphomas. N Y State J Med 66:2757\u20132764","journal-title":"N Y State J Med"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1099\/0022-1317-17-2-233","volume":"17","author":"DJ Moss","year":"1972","unstructured":"Moss DJ, Pope JH (1972) Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro. J General Virol 17:233\u2013236","journal-title":"J General Virol"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ijc.2910150316","volume":"15","author":"DJ Moss","year":"1975","unstructured":"Moss DJ, Pope JH (1975) EB Virus-associated nuclear antigen production and cell proliferation in adult peripheral blood leukocytes inoculated with the QIMR-WIL strain of EB virus. Int J Cancer 15:503\u2013511","journal-title":"Int J Cancer"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/268735a0","volume":"268","author":"DJ Moss","year":"1977","unstructured":"Moss DJ, Scott W, Pope JH (1977) An immunological basis for inhibition of transformation of human lymphocytes by EB virus. Nature 268:735\u2013736","journal-title":"Nature"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ijc.2910220604","volume":"22","author":"DJ Moss","year":"1978","unstructured":"Moss DJ, Rickinson AB, Pope JH (1978) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 22:662\u2013668","journal-title":"Int J Cancer"},{"key":"3_CR46","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ijc.2910230506","volume":"23","author":"DJ Moss","year":"1979","unstructured":"Moss DJ, Rickinson AB, Pope JH (1979) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures. Int J Cancer 23:618\u2013625","journal-title":"Int J Cancer"},{"key":"3_CR47","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/291664a0","volume":"291","author":"DJ Moss","year":"1981","unstructured":"Moss DJ, Rickinson AB, Wallace LE, Epstein MA (1981a) Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation. Nature 291:664\u2013666","journal-title":"Nature"},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/eji.1830110904","volume":"11","author":"DJ Moss","year":"1981","unstructured":"Moss DJ, Wallace LE, Rickinson AB, Epstein MA (1981b) Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro. Eur J Immunol 11:686\u2013693","journal-title":"Eur J Immunol"},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ijc.2910310609","volume":"31","author":"DJ Moss","year":"1983","unstructured":"Moss DJ, Burrows SR, Castelino DJ, Kane RG, Pope JH, Rickinson AB, Alpers MP, Heywood PF (1983a) A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea. Int J Cancer 31:727\u2013732","journal-title":"Int J Cancer"},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ijc.2910320307","volume":"32","author":"DJ Moss","year":"1983","unstructured":"Moss DJ, Chan SH, Burrows SR, Chew TS, Kane RG, Staples JA, Kunaratnam N (1983b) Epstein-Barr virus specific T-cell response in nasopharyngeal carcinoma patients. Int J Cancer 32:301\u2013305","journal-title":"Int J Cancer"},{"key":"3_CR51","first-page":"61","volume":"60","author":"DJ Moss","year":"1985","unstructured":"Moss DJ, Bishop CJ, Burrows SR, Ryan JM (1985) T lymphocytes in infectious mononucleosis. I. T cell death in vitro. Clin Exp Immunol 60:61\u201369","journal-title":"Clin Exp Immunol"},{"key":"3_CR52","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/331719a0","volume":"331","author":"DJ Moss","year":"1988","unstructured":"Moss DJ, Misko IS, Burrows SR, Burman K, McCarthy R, Sculley TB (1988) Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature 331:719\u2013721","journal-title":"Nature"},{"key":"3_CR53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/jama.1968.03140030037009","volume":"203","author":"JC Niederman","year":"1968","unstructured":"Niederman JC, McCollum RW, Henle G, Henle W (1968) Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies. JAMA, J Am Med Assoc 203:205\u2013209","journal-title":"JAMA, J Am Med Assoc"},{"key":"3_CR54","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1128\/JVI.75.8.3740-3752.2001","volume":"75","author":"S Nikiforow","year":"2001","unstructured":"Nikiforow S, Bottomly K, Miller G (2001) CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. J Virol 75:3740\u20133752","journal-title":"J Virol"},{"key":"3_CR55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/iai.11.1.42-51.1975","volume":"11","author":"J Nikoskelainen","year":"1975","unstructured":"Nikoskelainen J, Hanninen P (1975) Antibody response to Epstein-Barr virus in infectious mononucleosis. Infect Immun 11:42\u201351","journal-title":"Infect Immun"},{"key":"3_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/bmj.4.5936.72","volume":"4","author":"J Nikoskelainen","year":"1974","unstructured":"Nikoskelainen J, Leikola J, Klemola E (1974) IgM antibodies specific for Epstein-Barr virus in infectious mononucleosis without heterophil antibodies. Br Med J 4:72\u201375","journal-title":"Br Med J"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ijc.2910080312","volume":"8","author":"K Nilsson","year":"1971","unstructured":"Nilsson K, Klein G, Henle W, Henle G (1971) The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer 8:443\u2013450","journal-title":"Int J Cancer"},{"key":"3_CR58","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ijc.2910260216","volume":"26","author":"JR North","year":"1980","unstructured":"North JR, Morgan AJ, Epstein MA (1980) Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides. Int J Cancer 26:231\u2013240","journal-title":"Int J Cancer"},{"key":"3_CR59","doi-asserted-by":"publisher","first-page":"7504","DOI":"10.1073\/pnas.79.23.7504","volume":"79","author":"JR North","year":"1982","unstructured":"North JR, Morgan AJ, Thompson JL, Epstein MA (1982) Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes. Proc Natl Acad Sci USA 79:7504\u20137508","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR60","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00007890-197103000-00001","volume":"11","author":"JR Parker","year":"1971","unstructured":"Parker JR, Mowbray JF (1971) Peripheral blood leucocyte changes during human renal allograft rejection. Transplantation 11:201\u2013209","journal-title":"Transplantation"},{"key":"3_CR61","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1056\/NEJM197411282912201","volume":"291","author":"PK Pattengale","year":"1974","unstructured":"Pattengale PK, Smith RW, Perlin E (1974) Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers. N Engl J Med 291:1145\u20131148","journal-title":"N Engl J Med"},{"key":"3_CR62","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jnci\/56.3.485","volume":"56","author":"GR Pearson","year":"1976","unstructured":"Pearson GR, Orr TW (1976) Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens. J Natl Cancer Inst 56:485\u2013488","journal-title":"J Natl Cancer Inst"},{"key":"3_CR63","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/jvi.28.1.344-351.1978","volume":"28","author":"GR Pearson","year":"1978","unstructured":"Pearson GR, Qualtiere LF (1978) Papain solubilization of the Epstein-Barr virus-induced membrane antigen. J Virol 28:344\u2013351","journal-title":"J Virol"},{"key":"3_CR64","first-page":"989","volume":"45","author":"G Pearson","year":"1970","unstructured":"Pearson G, Dewey F, Klein G, Henle G, Henle W (1970) Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. J Natl Cancer Inst 45:989\u2013995","journal-title":"J Natl Cancer Inst"},{"key":"3_CR65","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ijc.2910030619","volume":"3","author":"JH Pope","year":"1968","unstructured":"Pope JH, Horne MK, Scott W (1968) Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int J Cancer 3:857\u2013866","journal-title":"Int J Cancer"},{"key":"3_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/222186a0","volume":"222","author":"JH Pope","year":"1969","unstructured":"Pope JH, Horne MK, Wetters EJ (1969) Significance of a complement-fixing antigen associated with herpes-like virus and detected in the Raji cell line. Nature 222:186\u2013187","journal-title":"Nature"},{"key":"3_CR67","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ijc.2910110302","volume":"11","author":"BM Reedman","year":"1973","unstructured":"Reedman BM, Klein G (1973) Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11:499\u2013520","journal-title":"Int J Cancer"},{"key":"3_CR68","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4049\/jimmunol.125.3.1269","volume":"125","author":"EL Reinherz","year":"1980","unstructured":"Reinherz EL, O\u2019Brien C, Rosenthal P, Schlossman SF (1980) The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. J Immunol 125:1269\u20131274","journal-title":"J Immunol"},{"key":"3_CR69","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/ijc.2910230505","volume":"23","author":"AB Rickinson","year":"1979","unstructured":"Rickinson AB, Moss DJ, Pope JH (1979) Long-term C-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures. Int J Cancer 23:610\u2013617","journal-title":"Int J Cancer"},{"key":"3_CR70","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ijc.2910250108","volume":"25","author":"AB Rickinson","year":"1980","unstructured":"Rickinson AB, Moss DJ, Pope JH, Ahlberg N (1980) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients. Int J Cancer 25:59\u201365","journal-title":"Int J Cancer"},{"key":"3_CR71","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ijc.2910270505","volume":"27","author":"AB Rickinson","year":"1981","unstructured":"Rickinson AB, Moss DJ, Allen DJ, Wallace LE, Rowe M, Epstein MA (1981a) Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line. Int J Cancer 27:593\u2013601","journal-title":"Int J Cancer"},{"key":"3_CR72","first-page":"4216","volume":"41","author":"AB Rickinson","year":"1981","unstructured":"Rickinson AB, Moss DJ, Wallace LE, Rowe M, Misko IS, Epstein MA, Pope JH (1981b) Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Res 41:4216\u20134221","journal-title":"Cancer Res"},{"key":"3_CR73","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0008-8749(84)90032-7","volume":"87","author":"AB Rickinson","year":"1984","unstructured":"Rickinson AB, Rowe M, Hart IJ, Yao QY, Henderson LE, Rabin H, Epstein MA (1984) T-cell-mediated regression of \u201cspontaneous\u201d and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. Cell Immunol 87:646\u2013658","journal-title":"Cell Immunol"},{"key":"3_CR74","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1099\/0022-1317-18-3-385","volume":"18","author":"G Rocchi","year":"1973","unstructured":"Rocchi G, Hewetson JF (1973) A practical and quantitative microtest for determination of neutralizing antibodies against Epstein-Barr virus. J General Virol 18:385\u2013391","journal-title":"J General Virol"},{"key":"3_CR75","unstructured":"Rooney CM, Rickinson AB, Moss DJ, Lenoir GM, Epstein MA (1985a). Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt\u2019s lymphoma. IARC Scientific Publications, pp 249\u2013264"},{"key":"3_CR76","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/317629a0","volume":"317","author":"CM Rooney","year":"1985","unstructured":"Rooney CM, Rowe M, Wallace LE, Rickinson AB (1985b) Epstein-Barr virus-positive Burkitt\u2019s lymphoma cells not recognized by virus-specific T-cell surveillance. Nature 317:629\u2013631","journal-title":"Nature"},{"key":"3_CR77","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549.417k32_1549_1555","volume":"92","author":"CM Rooney","year":"1998","unstructured":"Rooney CM, Smith CA, Ng CY, Loftin SK, Sixbey JW, Gan Y, Srivastava DK, Bowman LC, Krance RA, Brenner MK et al (1998) Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92:1549\u20131555","journal-title":"Blood"},{"key":"3_CR78","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1086\/315737","volume":"182","author":"MT Roos","year":"2000","unstructured":"Roos MT, van Lier RA, Hamann D, Knol GJ, Verhoofstad I, van Baarle D, Miedema F, Schellekens PT (2000) Changes in the composition of circulating CD8+\u00a0T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans. J Infect Dis 182:451\u2013458","journal-title":"J Infect Dis"},{"key":"3_CR79","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/j.1460-2075.1988.tb02787.x","volume":"7","author":"JB Rothbard","year":"1988","unstructured":"Rothbard JB, Taylor WR (1988) A sequence pattern common to T cell epitopes. The EMBO journal 7:93\u2013100","journal-title":"The EMBO journal"},{"key":"3_CR80","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ijc.2910350404","volume":"35","author":"M Rowe","year":"1985","unstructured":"Rowe M, Rooney CM, Rickinson AB, Lenoir GM, Rupani H, Moss DJ, Stein H, Epstein MA (1985) Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt\u2019s lymphoma. Int J Cancer 35:435\u2013441","journal-title":"Int J Cancer"},{"key":"3_CR81","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1056\/NEJM197512042932301","volume":"293","author":"I Royston","year":"1975","unstructured":"Royston I, Sullivan JL, Periman PO, Perlin E (1975) Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis. N Engl J Med 293:1159\u20131163","journal-title":"N Engl J Med"},{"key":"3_CR82","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/BF01241456","volume":"37","author":"H Schmitz","year":"1972","unstructured":"Schmitz H, Scherer M (1972) IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Archiv fur die gesamte Virusforschung 37:332\u2013339","journal-title":"Archiv fur die gesamte Virusforschung"},{"key":"3_CR83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.127.1.293","volume":"127","author":"J Seeley","year":"1981","unstructured":"Seeley J, Svedmyr E, Weiland O, Klein G, Moller E, Eriksson E, Andersson K, van der Waal L (1981) Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens. J Immunol 127:293\u2013300","journal-title":"J Immunol"},{"key":"3_CR84","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0140-6736(73)91148-3","volume":"1","author":"PJ Sheldon","year":"1973","unstructured":"Sheldon PJ, Hemsted EH, Papamichail M, Holborow EJ (1973) Thymic origin of atypical lymphoid cells in infectious mononucleosis. Lancet 1:1153\u20131155","journal-title":"Lancet"},{"key":"3_CR85","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.4049\/jimmunol.123.5.2150","volume":"123","author":"TC Shope","year":"1979","unstructured":"Shope TC, Kaplan J (1979) Inhibition of the in vitro outgrowth of Epstein-Barr virus-infected lymphocytes by TG lymphocytes. Journal of Immunology 123:2150\u20132155","journal-title":"Journal of immunology"},{"key":"3_CR86","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1073\/pnas.72.4.1622","volume":"72","author":"E Svedmyr","year":"1975","unstructured":"Svedmyr E, Jondal M (1975) Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci USA 72:1622\u20131626","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0304-3835(79)80071-3","volume":"7","author":"E Svedmyr","year":"1979","unstructured":"Svedmyr E, Klein G, Weiland O (1979) The EBV-carrying, beta2\u00a0M\/HLA deficient Burkitt lymphoma line Daudi is sensitive to EBV-specific killer T-cells of mononucleosis patients. Cancer Lett 7:15\u201320","journal-title":"Cancer Lett"},{"key":"3_CR88","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4049\/jimmunol.124.2.745","volume":"124","author":"DA Thorley-Lawson","year":"1980","unstructured":"Thorley-Lawson DA (1980) The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell. J Immunol 124:745\u2013751","journal-title":"J Immunol"},{"key":"3_CR89","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1073\/pnas.77.9.5307","volume":"77","author":"DA Thorley-Lawson","year":"1980","unstructured":"Thorley-Lawson DA, Geilinger K (1980) Monoclonal antibodies against the major glycoprotein (gp350\/220) of Epstein-Barr virus neutralize infectivity. Proc Natl Acad Sci USA 77:5307\u20135311","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR90","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1084\/jem.146.2.495","volume":"146","author":"DA Thorley-Lawson","year":"1977","unstructured":"Thorley-Lawson DA, Chess L, Strominger JL (1977) Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes. J Exp Med 146:495\u2013508","journal-title":"J Exp Med"},{"key":"3_CR91","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1056\/NEJM197911223012101","volume":"301","author":"G Tosato","year":"1979","unstructured":"Tosato G, Magrath I, Koski I, Dooley N, Blaese M (1979) Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N Engl J Med 301:1133\u20131137","journal-title":"N Engl J Med"},{"key":"3_CR92","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0092-8674(85)90103-5","volume":"42","author":"AR Townsend","year":"1985","unstructured":"Townsend AR, Gotch FM, Davey J (1985) Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42:457\u2013467","journal-title":"Cell"},{"key":"3_CR93","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.4049\/jimmunol.129.4.1421","volume":"129","author":"CD Tsoukas","year":"1982","unstructured":"Tsoukas CD, Carson DA, Fong S, Vaughan JH (1982) Molecular interactions in human T cell-mediated cytotoxicity to EBV II. Monoclonal antibody OKT3 inhibits a post-killer-target recognition\/adhesion step. J Immunol 129:1421\u20131425","journal-title":"J Immunol"},{"key":"3_CR94","volume-title":"Klinische Untersuchungen uberdas verhalten des Blutes bei akuten Infektions Krankheiten","author":"W Turk","year":"1898","unstructured":"Turk W (1898) Klinische Untersuchungen uberdas verhalten des Blutes bei akuten Infektions Krankheiten. Braumuiller, Vienna"},{"key":"3_CR95","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/269806a0","volume":"269","author":"T Tursz","year":"1977","unstructured":"Tursz T, Fridman WH, Senik A, Tsapis A, Fellous M (1977) Human virus-infected target cells lacking HLA antigens resist specific T-lymphocyte cytolysis. Nature 269:806\u2013808","journal-title":"Nature"},{"key":"3_CR96","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/eji.1830110905","volume":"11","author":"LE Wallace","year":"1981","unstructured":"Wallace LE, Moss DJ, Rickinson AB, McMichael AJ, Epstein MA (1981) Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants. Eur J Immunol 11:694\u2013699","journal-title":"Eur J Immunol"},{"key":"3_CR97","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/1097-0142(197505)35:5<1313::AID-CNCR2820350510>3.0.CO;2-B","volume":"35","author":"WM Wara","year":"1975","unstructured":"Wara WM, Wara DW, Phillips TL, Ammann AJ (1975) Elevated IGA in carcinoma of the nasopharynx. Cancer 35:1313\u20131315","journal-title":"Cancer"},{"key":"3_CR98","first-page":"123","volume":"1","author":"Y Zeng","year":"1979","unstructured":"Zeng Y, Liu YX, Wei JN, Zhu JS, Cai SL, Wang PZ, Zhong JM, Li RC, Pan WJ, Li EJ et al (1979) Serological mass survey of nasopharyngeal carcinoma (author\u2019s transl). Zhongguo yi xue ke xue yuan xue bao Acta Academiae Medicinae Sinicae 1:123\u2013126","journal-title":"Zhongguo yi xue ke xue yuan xue bao Acta Academiae Medicinae Sinicae"},{"key":"3_CR99","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ijc.2910290204","volume":"29","author":"Y Zeng","year":"1982","unstructured":"Zeng Y, Zhang LG, Li HY, Jan MG, Zhang Q, Wu YC, Wang YS, Su GR (1982) Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 29:139\u2013141","journal-title":"Int J Cancer"},{"key":"3_CR100","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000149391","volume":"20","author":"Y Zeng","year":"1983","unstructured":"Zeng Y, Zhong JM, Li LY, Wang PZ, Tang H, Ma YR, Zhu JS, Pan WJ, Liu YX, Wei ZN et al (1983) Follow-up studies on Epstein-Barr virus IgA\/VCA antibody-positive persons in Zangwu County, China. Intervirology 20:190\u2013194","journal-title":"Intervirology"},{"key":"3_CR101","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0065-2776(08)60262-X","volume":"27","author":"RM Zinkernagel","year":"1979","unstructured":"Zinkernagel RM, Doherty PC (1979) MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol 27:51\u2013177","journal-title":"Adv Immunol"},{"key":"3_CR102","doi-asserted-by":"crossref","unstructured":"zur Hausen H, Henle W, Hummeler K, Diehl V, Henle G (1967) Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol 1:830\u2013837","DOI":"10.1128\/jvi.1.4.830-837.1967"}],"container-title":["Current Topics in Microbiology and Immunology","Epstein Barr Virus Volume 1"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-22822-8_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T01:30:40Z","timestamp":1674264640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-22822-8_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319228211","9783319228228"],"references-count":102,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-22822-8_3","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"1 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}